Researchers Use Liquid Biopsies to Detect Relapse of Childhood Cancer Early
The study will collect small blood samples several times from 150 patients with high-risk neuroblastoma to be examined in laboratories.
Read MorePosted by Andy Lundin | Jan 29, 2024 | Unknown Origin & Other Cancer Types |
The study will collect small blood samples several times from 150 patients with high-risk neuroblastoma to be examined in laboratories.
Read MorePosted by Andy Lundin | Jan 24, 2024 | Prenatal Testing |
Natera has acquired certain assets from Invitae relating to its non-invasive prenatal screening and carrier screening business.
Read MorePosted by Andy Lundin | Jan 24, 2024 | Diagnostic Technologies |
New software combines AI and machine learning to measure the significance of specific genomic biomarkers to predict diseases in individuals.
Read MorePosted by Andy Lundin | Jan 19, 2024 | Company News |
Myriad Genetics will acquire Intermountain Precision Genomics’ Precise Tumor Test, the Precise Liquid Test, and a CLIA-certified laboratory.
Read MorePosted by Andy Lundin | Jan 17, 2024 | Unknown Origin & Other Cancer Types |
Researchers invented a new test that uses a small brush to allow dentists to screen for the most common form of oral cancer.
Read More